NO179995C - Fremgangsmåte for fremstilling av legemiddel-lipidsystemer med lav toksisitet inneholdende polyen-antibiotika - Google Patents
Fremgangsmåte for fremstilling av legemiddel-lipidsystemer med lav toksisitet inneholdende polyen-antibiotikaInfo
- Publication number
- NO179995C NO179995C NO884391A NO884391A NO179995C NO 179995 C NO179995 C NO 179995C NO 884391 A NO884391 A NO 884391A NO 884391 A NO884391 A NO 884391A NO 179995 C NO179995 C NO 179995C
- Authority
- NO
- Norway
- Prior art keywords
- lipid
- compositions
- preparation
- low
- systems containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
- G03B2227/00—Photographic printing apparatus
- G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
- G03B2227/325—Microcapsule copiers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Vehicle Step Arrangements And Article Storage (AREA)
- Catalysts (AREA)
- Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO944071A NO180147C (no) | 1987-03-05 | 1994-10-26 | Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid |
NO1998013C NO1998013I1 (no) | 1987-03-05 | 1998-03-25 | Amfotericin B Lipid-kompleks |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2215787A | 1987-03-05 | 1987-03-05 | |
US6990887A | 1987-07-06 | 1987-07-06 | |
US7930987A | 1987-07-29 | 1987-07-29 | |
PCT/US1988/000647 WO1988006443A1 (en) | 1987-03-05 | 1988-03-03 | Low toxicity drug-lipid systems |
Publications (4)
Publication Number | Publication Date |
---|---|
NO884391D0 NO884391D0 (no) | 1988-10-04 |
NO884391L NO884391L (no) | 1988-11-24 |
NO179995B NO179995B (no) | 1996-10-21 |
NO179995C true NO179995C (no) | 1997-01-29 |
Family
ID=27361805
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO884391A NO179995C (no) | 1987-03-05 | 1988-10-04 | Fremgangsmåte for fremstilling av legemiddel-lipidsystemer med lav toksisitet inneholdende polyen-antibiotika |
NO944071A NO180147C (no) | 1987-03-05 | 1994-10-26 | Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid |
NO1998012C NO1998012I1 (no) | 1987-03-05 | 1998-03-25 | Amfotericin B Lipid-kompleks |
NO1998013C NO1998013I1 (no) | 1987-03-05 | 1998-03-25 | Amfotericin B Lipid-kompleks |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944071A NO180147C (no) | 1987-03-05 | 1994-10-26 | Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid |
NO1998012C NO1998012I1 (no) | 1987-03-05 | 1998-03-25 | Amfotericin B Lipid-kompleks |
NO1998013C NO1998013I1 (no) | 1987-03-05 | 1998-03-25 | Amfotericin B Lipid-kompleks |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0282405B2 (da) |
KR (1) | KR970002870B1 (da) |
CN (1) | CN1044093C (da) |
AT (1) | ATE118169T1 (da) |
AU (1) | AU622405B2 (da) |
CA (1) | CA1338701C (da) |
DE (1) | DE3852961T3 (da) |
DK (1) | DK176010B1 (da) |
ES (1) | ES2070131T5 (da) |
FI (1) | FI102724B1 (da) |
GR (1) | GR3015916T3 (da) |
HK (1) | HK1007495A1 (da) |
IE (1) | IE67152B1 (da) |
IL (1) | IL85607A (da) |
LU (1) | LU88684I2 (da) |
NL (1) | NL990004I1 (da) |
NO (4) | NO179995C (da) |
NZ (1) | NZ223660A (da) |
PT (1) | PT86913B (da) |
WO (1) | WO1988006443A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178875A (en) * | 1991-01-14 | 1993-01-12 | The Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
US5830498A (en) * | 1987-10-16 | 1998-11-03 | Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
AU598958B2 (en) * | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
WO1990011780A1 (en) * | 1989-03-31 | 1990-10-18 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
US5188951A (en) * | 1990-04-17 | 1993-02-23 | The Liposome Company, Inc. | Enzymatic synthesis of soluble phosphatides from phospholipids |
US5556637A (en) * | 1990-08-06 | 1996-09-17 | A. Nattermann & Cie. Gmbh | Water containing liposome system |
DE4108902A1 (de) * | 1990-08-06 | 1992-02-13 | Nattermann A & Cie | Wasserhaltiges liposomensystem |
EP0556392A4 (en) * | 1990-11-06 | 1994-03-17 | Nippon Shinyaku Co Ltd | PROCESS FOR PRODUCING A FATTY EMULSION. |
US5534502A (en) * | 1990-11-06 | 1996-07-09 | Nippon Shinyaku Co. Ltd. | Process for producing fat emulsion |
AU664857B2 (en) * | 1991-08-14 | 1995-12-07 | Sequus Pharmaceuticals, Inc. | HIV-treatment method with low-toxicity amphotericin B |
CA2160118A1 (en) * | 1993-05-21 | 1994-12-08 | Patrick L. Ahl | Reduction of liposome-induced adverse physiological reactions |
US5716526A (en) * | 1994-01-14 | 1998-02-10 | The Liposome Company, Inc. | Method of separating materials from liposomes or lipid complexes |
US5902604A (en) | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
US6165997A (en) * | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
CN101325947A (zh) * | 2005-12-08 | 2008-12-17 | 惠氏公司 | 脂质体组合物 |
KR101132626B1 (ko) * | 2009-10-12 | 2012-04-02 | 주식회사 녹십자 | 난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법 |
EP2605751A1 (en) | 2010-08-20 | 2013-06-26 | Dr. Reddy's Laboratories, Ltd. | Phospholipid depot |
JP5877843B2 (ja) | 2010-10-22 | 2016-03-08 | ドクター レディズ ラボラトリーズ, インコーポレイテッド | 創傷を処置するための保存に安定した粘性リン脂質デポーの使用 |
WO2013168167A1 (en) | 2012-05-10 | 2013-11-14 | Painreform Ltd. | Depot formulations of a hydrophobic active ingredient and methods for preparation thereof |
CN107708672A (zh) | 2015-06-15 | 2018-02-16 | 华盛顿大学 | 用于延长血液和淋巴组织中的药物水平的多药脂质纳米颗粒组合物和相关方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310506A (en) * | 1979-02-22 | 1982-01-12 | California Institute Of Technology | Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species |
FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
US4604376A (en) * | 1982-04-21 | 1986-08-05 | Research Corporation | Enteric compounds and complexes |
US4436746A (en) * | 1982-09-30 | 1984-03-13 | Ciba-Geigy Corporation | Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles |
US4622219A (en) * | 1983-06-17 | 1986-11-11 | Haynes Duncan H | Method of inducing local anesthesia using microdroplets of a general anesthetic |
IL78930A0 (en) * | 1985-07-29 | 1986-09-30 | Abbott Lab | Lyophilized emulsion compositions for parenteral administration |
IL78929A0 (en) * | 1985-07-29 | 1986-09-30 | Abbott Lab | Microemulsion compositions for parenteral administration |
-
1988
- 1988-02-26 NZ NZ223660A patent/NZ223660A/en unknown
- 1988-02-29 CA CA000560121A patent/CA1338701C/en not_active Expired - Lifetime
- 1988-03-02 IL IL85607A patent/IL85607A/xx not_active IP Right Cessation
- 1988-03-03 AU AU17990/88A patent/AU622405B2/en not_active Expired
- 1988-03-03 IE IE60088A patent/IE67152B1/en not_active IP Right Cessation
- 1988-03-03 WO PCT/US1988/000647 patent/WO1988006443A1/en active IP Right Grant
- 1988-03-03 KR KR1019880701402A patent/KR970002870B1/ko not_active IP Right Cessation
- 1988-03-04 LU LU88684C patent/LU88684I2/fr unknown
- 1988-03-04 PT PT86913A patent/PT86913B/pt not_active IP Right Cessation
- 1988-03-04 EP EP88400520A patent/EP0282405B2/en not_active Expired - Lifetime
- 1988-03-04 DE DE3852961T patent/DE3852961T3/de not_active Expired - Lifetime
- 1988-03-04 ES ES88400520T patent/ES2070131T5/es not_active Expired - Lifetime
- 1988-03-04 AT AT88400520T patent/ATE118169T1/de active
- 1988-03-05 CN CN88101864A patent/CN1044093C/zh not_active Expired - Lifetime
- 1988-10-04 NO NO884391A patent/NO179995C/no not_active IP Right Cessation
-
1989
- 1989-03-01 DK DK198900980A patent/DK176010B1/da not_active IP Right Cessation
- 1989-09-04 FI FI894161A patent/FI102724B1/fi not_active IP Right Cessation
-
1994
- 1994-10-26 NO NO944071A patent/NO180147C/no not_active IP Right Cessation
-
1995
- 1995-04-25 GR GR950401037T patent/GR3015916T3/el unknown
-
1998
- 1998-03-25 NO NO1998012C patent/NO1998012I1/no unknown
- 1998-03-25 NO NO1998013C patent/NO1998013I1/no unknown
- 1998-06-25 HK HK98106740A patent/HK1007495A1/xx not_active IP Right Cessation
-
1999
- 1999-01-26 NL NL990004C patent/NL990004I1/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO179995C (no) | Fremgangsmåte for fremstilling av legemiddel-lipidsystemer med lav toksisitet inneholdende polyen-antibiotika | |
RU94027569A (ru) | Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения | |
ES2044843T3 (es) | Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos. | |
DE3269241D1 (en) | Triazoloquinazolines, process for their preparation and pharmaceutical compositions containing them | |
DE3175733D1 (en) | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | |
PT84996A (de) | Pharmazeutische zubereitung zur behandlung bakterieller infektionen | |
IL88124A0 (en) | Pharmaceuticals,phosphorus-containing-2-isoxazolines and isoxazoles contained therein and processes for the preparation of these compounds | |
HU913937D0 (en) | 10,11,12,13-tetrahydro-demicosine derivatives, method for producing them and pharmaceutical preparatives containing said compounds | |
EP0281092A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
ITMI930273A0 (it) | Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |